These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10468635)

  • 1. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.
    Gomeza J; Zhang L; Kostenis E; Felder C; Bymaster F; Brodkin J; Shannon H; Xia B; Deng C; Wess J
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10483-8. PubMed ID: 10468635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.
    Gomeza J; Zhang L; Kostenis E; Felder CC; Bymaster FP; Brodkin J; Shannon H; Xia B; Duttaroy A; Deng CX; Wess J
    Life Sci; 2001 Apr; 68(22-23):2457-66. PubMed ID: 11392613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.
    Yamada M; Lamping KG; Duttaroy A; Zhang W; Cui Y; Bymaster FP; McKinzie DL; Felder CC; Deng CX; Faraci FM; Wess J
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14096-101. PubMed ID: 11707605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
    Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
    J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice.
    Bymaster FP; Carter PA; Zhang L; Falcone JF; Stengel PW; Cohen ML; Shannon HE; Gomeza J; Wess J; Felder CC
    Life Sci; 2001 Apr; 68(22-23):2473-9. PubMed ID: 11392615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.
    Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P
    Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.
    Gomeza J; Shannon H; Kostenis E; Felder C; Zhang L; Brodkin J; Grinberg A; Sheng H; Wess J
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1692-7. PubMed ID: 9990086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.
    Bymaster FP; Carter PA; Yamada M; Gomeza J; Wess J; Hamilton SE; Nathanson NM; McKinzie DL; Felder CC
    Eur J Neurosci; 2003 Apr; 17(7):1403-10. PubMed ID: 12713643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP; Zhou LW; Weiss B
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens.
    Onali P; Olianas MC
    Eur J Pharmacol; 2002 Jul; 448(2-3):105-11. PubMed ID: 12144929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
    Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
    Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
    Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
    Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
    Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.
    Duttaroy A; Gomeza J; Gan JW; Siddiqui N; Basile AS; Harman WD; Smith PL; Felder CC; Levey AI; Wess J
    Mol Pharmacol; 2002 Nov; 62(5):1084-93. PubMed ID: 12391271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.